These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15124766)

  • 21. Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.
    Zhou F; Shiroishi M; Gong H; Zee CS
    J Magn Reson Imaging; 2010 Apr; 31(4):789-95. PubMed ID: 20373421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis pathology in the normal and abnormal appearing white matter of the corpus callosum by diffusion tensor imaging.
    Coombs BD; Best A; Brown MS; Miller DE; Corboy J; Baier M; Simon JH
    Mult Scler; 2004 Aug; 10(4):392-7. PubMed ID: 15327035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-oriented analysis in vivo using diffusion tensor imaging for normal-appearing brain tissue in multiple sclerosis.
    Terajima K; Matsuzawa H; Tanaka K; Nishizawa M; Nakada T
    Neuroimage; 2007 Oct; 37(4):1278-85. PubMed ID: 17689265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coefficient D(av) is more sensitive than fractional anisotropy in monitoring progression of irreversible tissue damage in focal nonactive multiple sclerosis lesions.
    Castriota-Scanderbeg A; Fasano F; Hagberg G; Nocentini U; Filippi M; Caltagirone C
    AJNR Am J Neuroradiol; 2003 Apr; 24(4):663-70. PubMed ID: 12695200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.
    Zivadinov R; Hagemeier J; Bergsland N; Tavazzi E; Weinstock-Guttman B
    Eur J Neurol; 2018 Mar; 25(3):584-e36. PubMed ID: 29316038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis.
    Griffin CM; Chard DT; Ciccarelli O; Kapoor B; Barker GJ; Thompson AI; Miller DH
    Mult Scler; 2001 Oct; 7(5):290-7. PubMed ID: 11724444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Directional diffusion in relapsing-remitting multiple sclerosis: a possible in vivo signature of Wallerian degeneration.
    Henry RG; Oh J; Nelson SJ; Pelletier D
    J Magn Reson Imaging; 2003 Oct; 18(4):420-6. PubMed ID: 14508778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging.
    Ge Y; Law M; Johnson G; Herbert J; Babb JS; Mannon LJ; Grossman RI
    J Magn Reson Imaging; 2004 Jul; 20(1):1-7. PubMed ID: 15221802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of normal-appearing white matter in multiple sclerosis using quantitative susceptibility mapping in conjunction with diffusion tensor imaging.
    Yu FF; Chiang FL; Stephens N; Huang SY; Bilgic B; Tantiwongkosi B; Romero R
    Neuroradiology; 2019 Jan; 61(1):71-79. PubMed ID: 30539215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis.
    Giorgio A; Palace J; Johansen-Berg H; Smith SM; Ropele S; Fuchs S; Wallner-Blazek M; Enzinger C; Fazekas F
    J Magn Reson Imaging; 2010 Feb; 31(2):309-16. PubMed ID: 20099343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple white matter tract abnormalities underlie cognitive impairment in RRMS.
    Yu HJ; Christodoulou C; Bhise V; Greenblatt D; Patel Y; Serafin D; Maletic-Savatic M; Krupp LB; Wagshul ME
    Neuroimage; 2012 Feb; 59(4):3713-22. PubMed ID: 22062194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
    Filippi M; Preziosa P; Pagani E; Copetti M; Mesaros S; Colombo B; Horsfield MA; Falini A; Comi G; Lassmann H; Rocca MA
    Mult Scler; 2013 Apr; 19(4):418-26. PubMed ID: 22907944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions.
    Tievsky AL; Ptak T; Farkas J
    AJNR Am J Neuroradiol; 1999 Sep; 20(8):1491-9. PubMed ID: 10512236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole brain white matter changes revealed by multiple diffusion metrics in multiple sclerosis: a TBSS study.
    Liu Y; Duan Y; He Y; Yu C; Wang J; Huang J; Ye J; Parizel PM; Li K; Shu N
    Eur J Radiol; 2012 Oct; 81(10):2826-32. PubMed ID: 22172535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion tensor imaging changes of the cortico-thalamic-striatal tracts correlate with fatigue and disability in people with relapsing-remitting MS.
    Alshehri A; Koussis N; Al-Iedani O; Arm J; Khormi I; Lea S; Lea R; Ramadan S; Lechner-Scott J
    Eur J Radiol; 2024 Jan; 170():111207. PubMed ID: 37988961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
    Bezukladova S; Tuisku J; Matilainen M; Vuorimaa A; Nylund M; Smith S; Sucksdorff M; Mohammadian M; Saunavaara V; Laaksonen S; Rokka J; Rinne JO; Rissanen E; Airas L
    Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multislice brain myelin water fractions at 3T in multiple sclerosis.
    Oh J; Han ET; Lee MC; Nelson SJ; Pelletier D
    J Neuroimaging; 2007 Apr; 17(2):156-63. PubMed ID: 17441837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusion tensor magnetic resonance imaging in multiple sclerosis.
    Filippi M; Cercignani M; Inglese M; Horsfield MA; Comi G
    Neurology; 2001 Feb; 56(3):304-11. PubMed ID: 11171893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations.
    Ciccarelli O; Werring DJ; Wheeler-Kingshott CA; Barker GJ; Parker GJ; Thompson AJ; Miller DH
    Neurology; 2001 Apr; 56(7):926-33. PubMed ID: 11294931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study.
    Klistorner A; Wang C; Yiannikas C; Parratt J; Dwyer M; Barton J; Graham SL; You Y; Liu S; Barnett MH
    Neuroimage Clin; 2018; 17():1028-1035. PubMed ID: 29387524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.